1 Induction of remission (CDAI < 150) or clinical improvement |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1 Salofalk (1.5 g/day) |
1 |
30 |
Risk Ratio (M‐H, Random, 95% CI) |
1.18 [0.82, 1.70] |
1.2 Salofalk (3.0 g/day) |
1 |
50 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.75, 1.18] |
2 Adverse events |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.1 Salofalk (1.5 g/day) |
1 |
30 |
Risk Ratio (M‐H, Random, 95% CI) |
0.11 [0.01, 1.90] |
2.2 Salofalk (3.0 g/day) |
1 |
50 |
Risk Ratio (M‐H, Random, 95% CI) |
0.54 [0.15, 1.93] |